Revvity, Inc. (RVTY) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Medical - Diagnostics & Research उद्योग. कंपनी का मुख्यालय है Waltham, MA, United States. वर्तमान CEO हैं Prahlad R. Singh.
RVTY के पास है IPO तिथि 1965-07-06, 11,000 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NYSE, बाजार पूंजीकरण $10.45B.
Revvity, Inc. is a global provider of products, services, and solutions serving the diagnostics, life sciences, and applied services markets. Operating through two primary segments, Discovery & Analytical Solutions and Diagnostics, the company offers a comprehensive portfolio including analytical instruments, reagents, software, and imaging technologies for research and industrial applications across pharmaceuticals, environmental monitoring, food production, and chemical analysis. The Diagnostics segment specializes in instruments and assay platforms for genetic disorder detection, infectious disease testing, and genomic workflows, serving pharmaceutical companies, biotechnology firms, laboratories, academic institutions, and healthcare organizations worldwide. Founded in 1937 and headquartered in Waltham, Massachusetts, Revvity rebranded from PerkinElmer, Inc. in April 2023 to reflect its evolved market positioning and capabilities.
